Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia - Wikidata - awgldk - TriplyDB

Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia

Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia

http://www.wikidata.org/entity/Q35031434

about

Artemether for severe malaria How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution Can Rapid Diagnostic Testing for Malaria Increase Adherence to Artemether-Lumefantrine?: A Randomized Controlled Trial in Uganda.Intervention to promote patients' adherence to antimalarial medication: a systematic review.Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection.The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.Coartem(®): a decade of patient-centric malaria management.Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.Pharmacogenomic biomarkers in dermatologic drugs.Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling.Reassessing an old claim: natural selection of hemizygotes and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.Adherence to treatment with artemether-lumefantrine or amodiaquine-artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial.

P2860

Q24193663-39D04419-9A57-4C8F-BCF4-9B9D36D2716B Q26823483-76BCD01E-F540-4550-AACD-B3C427FFBC06 Q28538749-52ED0AC6-F3CC-4B23-8664-49C89EE982DC Q35137054-C50E5D86-D959-42F5-B06B-E57C44F4E502 Q36776118-A56CEA8E-7AD4-4C5D-8EC6-6835E20CDBE5 Q37456044-9301614C-F82C-4CC9-B438-55E917798C41 Q37635143-4825F685-8A7C-4ECF-8CC8-85978BCB04B8 Q37723447-FCC7C885-970B-4942-9BBE-A215C5A1C8D8 Q37739562-637361F2-7B89-40D0-812B-5C077FEE8F2D Q38529669-53DC61DD-8240-4DF1-A619-2B2AD784E420 Q38973256-7C88F845-CD15-4089-B287-91C383DE4F48 Q39042892-AF24B887-A197-466E-B872-F5D2904A612B Q39525461-78111D0A-4F4F-4C8D-AAF7-6AD64A6DEFA9 Q41929420-B2BCB9F3-EF55-4F64-B789-670584BE5FA3 Q43924014-46FA483A-953E-4E29-9BC0-F1B6BEA3AA80 Q46745288-0F549E27-BA44-4574-9464-2DEF70D28DB0 Q55491745-13BF6668-50D9-40F6-A991-E5BDD5EBA166

P2860

Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia

http://www.wikidata.org/entity/Q35031434

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Randomized trial of safety and ...... aria in children in the Gambia

@ast

Randomized trial of safety and ...... aria in children in the Gambia

@en

type

label

Randomized trial of safety and ...... aria in children in the Gambia

@ast

Randomized trial of safety and ...... aria in children in the Gambia

@en

prefLabel

Randomized trial of safety and ...... aria in children in the Gambia

@ast

Randomized trial of safety and ...... aria in children in the Gambia

@en

P1433

Q35031434-7B3AAEEC-3DA3-478C-B593-0456B6FD8185

P1476

Q35031434-D2A75C42-89C2-4F8A-8492-17792BCF5BCF

P2093

Q35031434-356031B6-34C9-41A0-9D32-0303EB5A3E52

Q35031434-44DFC815-143D-4C39-A461-26BD54D2958C

Q35031434-63C42033-665F-4EB3-8FC4-DAA3699E94F0

Q35031434-8D0EE534-ED71-4AD1-BAD5-0E7E6C6F5A2F

Q35031434-BCB265C8-72A5-4D15-88CC-F4ADF4887DBB

Q35031434-BE244B00-8137-43C5-813B-734C664B0415

Q35031434-CD518AC5-0024-4CC8-B295-3C8E79FF041C

Q35031434-DD8CC720-2D0B-44ED-8B7F-1E2684BD8F1E

Q35031434-E2318DCD-5B40-4414-B2B7-281B64681B12

Q35031434-FCD4819A-C803-407A-84F8-2251847C0F72

P2860

Q35031434-130A66EC-F2C6-4262-B519-9A571E8EDFE0

Q35031434-130BA182-7A45-4BFE-8FF4-A82BA3922A79

Q35031434-1769B20C-F7CF-4125-98DC-4EDD8C73A8EC

Q35031434-2DF6A9C1-D759-4DCA-8901-644850A3FF2E

Q35031434-300459AA-AE59-4D7D-B1C1-3B656016D6A6

Q35031434-33431F1D-0108-4B59-A27E-1A7D44AE1C45

Q35031434-3852B030-1500-4B94-B184-EED1E45192C1

Q35031434-3F2DDB24-7F8E-4E61-B27D-252EAA6F3100

Q35031434-4B48DD5F-E864-4352-8C62-5EA284900FF8

Q35031434-4CB1D5F4-5E35-4ABD-A924-038AEE767C45

P304

Q35031434-C8953E3F-3FC4-4C1A-8210-2F23C23D642C

P31

Q35031434-3B731948-B42D-4014-9112-2F9A573E042D

P356

Q35031434-22A3D85E-0BB8-4DBC-A0A3-8F6CC8DCE15D

P407

Q35031434-2277C8AC-778D-4659-BD50-780318E8AF50

P433

Q35031434-1ECA3529-35E1-4A92-BAEE-2FB40B04F193

P478

Q35031434-E0079016-84DB-4F9E-BE2E-DE1E2639CCFE

P50

Q35031434-0178B920-CF3D-4F9A-A4A0-BA46BD79F928

Q35031434-5F2DC5A0-1589-4399-A236-02B9B3826C21

Q35031434-63F8A042-C199-4E94-B47C-96CA32C3468A

Q35031434-6D1CBB2B-C163-4BAC-B2C5-C7844A4F8F01

Q35031434-7D09A2E1-B96A-4D2A-B23B-EA5EC845427D

Q35031434-86A54017-35DC-4F97-9098-783BCE1A40E2

P577

Q35031434-07381EF0-48AB-409F-A22E-A1C047CEF10D

P5875

Q35031434-EDBBFAB2-361E-45F6-8DAB-4E9970AE3864

P698

Q35031434-C67BC8FA-F20C-495D-89CA-A6A33CA13B03

P921

Q35031434-26F28AC3-47DC-4DA2-9151-372E5DFAD43F

Q35031434-653EADA9-C355-47CA-98C4-FF12C4E3A8AB

P932

Q35031434-60EA2A08-DBE0-456B-A803-3205FFA80844

P356

JOURNAL.PONE.0017371

P1433

P1476

Randomized trial of safety and ...... aria in children in the Gambia

@en

P2093

Beth Temple

http://www.w3.org/2001/XMLSchema#string

Fanta Njie

http://www.w3.org/2001/XMLSchema#string

Fatou Sisay Joof

http://www.w3.org/2001/XMLSchema#string

Giorgio Sirugo

http://www.w3.org/2001/XMLSchema#string

Majidah Adiamoh

http://www.w3.org/2001/XMLSchema#string

Mathurin Diatta

http://www.w3.org/2001/XMLSchema#string

Paul Snell

http://www.w3.org/2001/XMLSchema#string

Ramatoulie Janha

http://www.w3.org/2001/XMLSchema#string

Samuel Dunyo

http://www.w3.org/2001/XMLSchema#string

Yin Bun Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria

The development of Lapdap, an affordable new treatment for malaria

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum

High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency

X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria

Comparison of two simple methods for determining malaria parasite density.

P304

e17371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0017371

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

David J. Conway

Cyrille Bisseye

Paul J. Milligan

Davis C Nwakanma

P577

2011-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51213031

http://www.w3.org/2001/XMLSchema#string

P698

21666744

http://www.w3.org/2001/XMLSchema#string

P921

P932

3110183

http://www.w3.org/2001/XMLSchema#string